| | March 20156CIOReviewCopyright © 2015 CIOReview, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.CIOReviewMARCH 31- 2015Mailing AddressCIOReview44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510.402.1463, F:510-894-8405 MARCH 31 2015, Volume 4 SE 14 Published by CIOReview To subscribe to CIOReviewVisit www.cioreview.com Editor-in-Chief Pradeep ShankarEditorial StaffSalesAishwarya Kannan Aron Peter Jenna VegasMathew JacobAlex D' Souza Derek James Joe Philip Sonia SacharT:510.565.7559 VisualizersStephen ThomasChetan.N PHARMA & LIFE SCIENCES TECHNOLOGY SPECIALCIOReview Sarah Mathew sarah.mathew@cioreview.com Stephen Thomasstephen.thomas@cioreview.com Benny ThomasBenny@cioreview.comThe life sciences industry is battling patent cliffs, falling R&D productivity, increased regulations, cost pressures, price-sensitive markets and industry consolidation. Organizations are facing the dual challenge of identifying the right, "future-proofed" business model while addressing today's operational demands. Added to this, life sciences organizations are facing unprecedented challenges to improve drug development and efficacy while driving toward more targeted and personalized drugs, devices, therapies, and care. As life sciences organizations face newer challenges, leaders must explore a new course to address the changing climate for health care -- one driven by patients and focused on health outcomes.For sustained success in the rapidly changing competitive market, life sciences companies will look for disruptive technologies to foster product innovation, market expansion, and revenue growth. Pharma companies are already relying heavily on technology for process management, data analytics, content management, identify cost effective therapy and to engage with the customers. Big data is becoming an integral part of life sciences organizations encompassing the entire value chain. Leveraging data management and analytics technologies, life sciences organizations are turning data into innovative insights. Whether it's driving process improvements to clinical operations, increasing sales effectiveness, or enhancing drug safety, pharma companies are redefining the way they leverage technology. So much so that it is expected that technology spending of the global life sciences industry will reach $40.8 billion by 2017.In this special edition of CIO Review, CIOs from leading pharmaceutical and life sciences companies share their experiences of leveraging technology in their business environment. We also present to you most promising pharma and life sciences solution providers and consulting companies and highlight what these selected vendors are doing for their clients. We hope this information will give you a comprehensive understanding of what technologies are available, which is right for you, and how these solutions will impact your business. We would love to hear your experiences of how technology is playing a critical role in driving your business.Pradeep Shankar Editor-in-Chief editor@cioreview.comEditorialFuture Proofing the Business Models
< Page 5 | Page 7 >